How Much Does Immunotherapy with Keytruda (Pembolizumab) Cost in India?
Immunotherapy with Keytruda in India costs from $2,500 to $5,200. The total price depends on the official drug MRP, pharmacy discounts, and the prescribed dosage based on patient weight. In the US, this procedure costs $17,800 on average. Most clinics include the medication, administration fees, oncologist consultations, and routine blood monitoring in their estimates.
- Medication per vial. Typically costs between 15% to 20% less when sourced through authorized hospital pharmacies.
- Treatment cycle cost. Requires two 100 mg vials every three weeks for standard adult dosing protocols.
- Medical hubs. Treatment is primarily centered in major cities like Delhi, Gurgaon, Bengaluru, and Nashik.
- Diagnostic monitoring. Regular PET-CT scans and imaging add approximately 5-10% to the total cycle budget.
Bookimed Expert Insight. Indian centers like HCG Manavata Cancer Centre use IBM Watson for Oncology to ensure 96% accuracy in treatment protocols. Patients often choose Apollo Hospital Indraprastha because oncology prices are two to three times lower than in Western countries. Facilities like Fortis Gurgaon offer advanced CyberKnife VSI systems to complement immunotherapy for hard-to-reach tumors. Dr. Girish Badarkhe at HCG Manavata specifically manages complex blood disorders using Keytruda for both adults and children.
| India | Turkey | Austria | |
|---|---|---|---|
| Immunotherapy with Keytruda (Pembolizumab) | from $2,500 | from $2,800 | ≈ $5,800 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Discover the Best Immunotherapy with Keytruda (Pembolizumab) Clinics in India: 7 Verified Options and Prices
HCG Manavata Cancer Centre
Raj Nagarkar




Immunotherapy with Keytruda (Pembolizumab) in India: Your Travel Plan
Day 1: Arrival in India
- Upon landing in India, you should have all necessary documents, including your passport, visa, and medical records.
- Contact the clinic immediately to confirm your arrival and schedule your initial consultation.
- Check into your accommodation and rest. You need to be prepared for a busy schedule ahead.
- Organize your medical documents, including previous slides/blocks, MRI/CT films, and reports for upcoming consultations.
- Keep a contact list of the clinic and emergency numbers handy for any immediate needs.
Day 2: Initial Consultation and Investigations
- Attend your scheduled consultation at the clinic with your oncologist.
- Undergo a thorough clinical evaluation to assess your current health status.
- Bring all previous medical records for the review of histopathology.
- Prepare for a PET CT scan, which is crucial for evaluating the extent of cancer.
- Discuss any additional investigations that might be required.
- Ask questions about the treatment plan and clarify doubts regarding immunotherapy with Keytruda (Pembrolizumab).
Day 3: Review of Investigations and Treatment Planning
- Meet with your oncologist to review the results from the PET CT and histopathology.
- Discuss the possibility of combining chemotherapy with immunotherapy based on the findings.
- Consider any advice regarding additional treatments like surgery or radiotherapy.
- If a repeat biopsy is necessary, schedule it promptly. It is vital for confirming treatment pathways.
- Ensure all your questions and concerns about the treatment procedure and its side effects are addressed.
Day 4: Rest and Preparation
- Take this day to rest and prepare mentally for the treatment ahead.
- Ensure you have all medications and prescriptions ready.
- Stay hydrated and maintain a balanced diet to keep your strength up.
- Contact the clinic if you have any last-minute questions or need further clarification on the treatment process.
- Review your travel and accommodation arrangements for any necessary adjustments.
Day 5: Commencement of Immunotherapy with Keytruda (Pembrolizumab)
- Arrive at the clinic on time for your scheduled immunotherapy session.
- Undergo pre-treatment assessments to ensure you are fit for the session.
- Receive your first dose of Keytruda (Pembrolizumab) under the supervision of medical staff.
- Stay at the clinic for a few hours post-treatment for observation and to monitor any immediate side effects.
- Discuss the schedule for the next cycle and any follow-up appointments needed.
Day 6: Post-Treatment Care and Monitoring
- Monitor yourself for any side effects like fatigue, nausea, or fever. Report these to the clinic if they occur.
- Follow any dietary or lifestyle recommendations provided by your healthcare team.
- Maintain a log of any symptoms or changes in your condition to discuss during your next visit.
- Keep in touch with the clinic for any guidance or support needed.
- Plan for relaxation activities to aid in recovery and stress management.
Day 7: Follow-up and Future Planning
- Attend any scheduled follow-up appointments to assess your response to the treatment.
- Discuss the treatment's progress and any necessary adjustments with your oncologist.
- Plan the next steps in your treatment, including further cycles of immunotherapy or additional interventions.
- Ensure you have all necessary documentation for your records and future reference.
- Confirm your travel arrangements and prepare for your return home. Ensure you have a plan for continued care and monitoring.
Returning Home
- Before departing, ensure you have all medical documents and prescriptions required for ongoing treatment.
- Maintain communication with your healthcare team for remote follow-ups if needed.
- Adhere to the post-treatment care plan provided by your oncologist to ensure continued
Our Trusted Doctors
View all Doctors
Raj Nagarkar
30 years of surgical oncology experience – Dr. Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata Cancer Centre.
- Trained at Tata Memorial Hospital – India's premier cancer center
- Specializes in breast and thoracic surgical oncology
- Involved in 200+ clinical trials for new cancer treatments
- Professor for surgical oncology at Delhi National Board

Prakash Pandit
Dr. Prakash Pandit specializes in advanced radiation oncology techniques at HCG Manavata Cancer Centre, focusing on precise cancer treatments.
- MD in Radiation Oncology with expertise in Tomotherapy-H
- Uses Linear Accelerator & Brachytherapy for targeted therapy
- Consultant with a focus on innovative cancer treatments

Sridhar P.S.
Dr. Sridhar specializes in radiotherapy with extensive training in cancer treatment at top Indian institutions like Banaras Hindu University.
- Over 30 years of experience in radiotherapy
- Member of the Society for Neuro-Oncology and Bangalore Oncology Group
- Trained at prestigious institutions including Mysore University and Banaras Hindu University
- Diplomate of National Board in radiotherapy
- Specializes in advanced cancer treatment techniques

Chaitainya Borde
Dr. Chaitainya Borde has performed over 30,000 PET scans and treated 1,000+ thyroid cancer patients at HCG Manavata Cancer Centre.
- 11 years of experience in nuclear medicine
- Specializes in radioiodine & Lu-177 RN therapies
- Proficient in all types of nuclear and PET-CT scans
- Published papers in medical journals
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
Fast Facts about Immunotherapy with Keytruda (Pembolizumab)

Immunotherapy with Keytruda (Pembolizumab)
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
FAQ about Immunotherapy with Keytruda (Pembolizumab) in India
What is Keytruda (Pembrolizumab) and how does it work?
Keytruda is an immunotherapy medication that reboots the immune system to identify and kill cancer cells. Unlike chemotherapy, this monoclonal antibody blocks the PD-1 pathway, preventing tumors from hiding and allowing T cells to naturally destroy advanced cancers like melanoma or lung carcinoma.
- Mechanism of action: It blocks PD-1 receptors so T cells can recognize and attack cancerous tumors.
- Treatment frequency: Administered via intravenous infusion every 3 or 6 weeks in clinical settings.
- Targeted cancers: Effectively treats melanoma, non-small cell lung cancer, and MSI-H positive solid tumors.
- Side effects: Potential immune-mediated inflammation affecting organs like the lungs, colon, or liver.
Bookimed Expert Insight: India has become a global hub for Keytruda due to high-volume expertise at centers like HCG Manavata Cancer Centre, where teams have performed over 50,000 surgeries. While US infusions average $17,800, Indian clinics offer the same immunotherapy starting at $2,500, saving patients up to 78%.
Patient Consensus: Patients emphasize that immunotherapy feels different from chemotherapy because it revs up immunity rather than poisoning cells. many report that monitoring biomarkers like PD-L1 was crucial for predicting their individual success with the drug.
Is Keytruda approved for use in India?
Keytruda is approved in India by the Drug Controller General of India (DCGI). It is cleared for multiple cancer indications including non-small cell lung cancer, melanoma, and triple-negative breast cancer. Treatment is available at JCI-accredited facilities like Artemis Hospitals and Apollo Hospital Indraprastha.
- Approved indicators: DCGI covers renal cell carcinoma, cervical cancer, and esophageal cancer cases.
- Prescription requirements: Dispensing requires a valid prescription from a board-certified oncologist in India.
- Typical pricing: Immunotherapy with Keytruda in India ranges from $2,500 to $5,200.
- Cost savings: Patients save up to 78% compared to average US prices of $17,800.
Bookimed Expert Insight: Success with Keytruda in India often depends on doctor experience with immunotherapy protocols. Dr. Shruti Kate at HCG Manavata Cancer Centre specializes specifically in these treatments. Many top Indian clinics now also use IBM Watson AI platforms to verify treatment compatibility.
Patient Consensus: Success depends on confirming drug availability for your specific cancer subtype before traveling. Patients highly value the cost difference but recommend asking about immune-related side effect monitoring plans.












